Research has shown that melatonin can inhibit the proliferation of bladder cancer cells and promote their apoptosis by suppressing the O-GlcNAcylation of cyclin-dependent-like kinase 5 (CDK5) and reducing the expression level of CDK5 (Wu J. et al., 2021). This evidence concerns the gene CDK5 and urinary bladder cancer.